Evitalife Pharma Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2012.
2012 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Evitalife Pharma Private Limited

Evitalife Pharma Private Limited, a active private limited company, was established on 14 January 2012 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233DL2012PTC229963. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹2.00 M.

It upholds a compliant status. Its leadership includes Rohit Kumar Barnwal (Director), Subhash Kumar (Director). Past directors included Gaurav Kumar, Subhash Kumar. It holds ₹3.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1869/A-14 Basement Govindpuri Extension Kalkaji, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233DL2012PTC229963

  • Registration Number

    229963

  • Incorporation Date

    14 January 2012

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹2.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 2.00 M
  • Company Age 14 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.20 M
  • Revenue Growth **** 141.56%
  • Profit Growth **** 135.11%
  • Ebitda **** 134.44%
  • Net Worth 144.57%
  • Total Assets **** 209.53%
Company report

Evitalife Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Evitalife Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Evitalife Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rohit Kumar Barnwal Director 14 Jan 2012 Current
Subhash Kumar Director 13 Mar 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Mar 2016 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Evitalife Pharma.

Evitalife Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 141.56% increase. The company also saw a substantial improvement in profitability, with a 135.11% increase in profit. The company's net worth Soared by an impressive increase of 144.57%.

Evitalife Pharma revenue growth over time
Evitalife Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 141.56%
*******
*******
*******
*******
Revenue from Operations
*******
 141.56%
*******
*******
*******
*******
Total Assets
*******
 209.53%
*******
*******
*******
*******
Profit or Loss
*******
 135.11%
*******
*******
*******
*******
Net Worth
*******
 144.57%
*******
*******
*******
*******
EBITDA
*******
 134.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Evitalife Pharma?

In 2021, Evitalife Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.32 Cr
Latest Charge Details
Date Lender Amount Status
10 Jan 2025 Canara Bank ₹0.70 M Open
04 Aug 2021 Canara Bank ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Evitalife Pharma?

Unlock and access historical data on people associated with Evitalife Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Evitalife Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evitalife Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Evitalife Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Evitalife Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Evitalife Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 0.70 M with Charge ID 101028485 was registered on 10 Jan 2025. was documented.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 2.50 M with Charge ID 100476304 was registered on 04 Aug 2021. was documented.

  • Director Appointment

    Progress on Subhash Kumar was appointed as a Director was appointed as a Director on 13 Mar 2016 & has been associated with this company since 9 years 11 months . was documented.

  • Director Appointment

    Rohit Kumar Barnwal was appointed as a Director was appointed as a Director on 14 Jan 2012 & has been associated with this company since 14 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Evitalife Pharma Private Limited?

The CIN of Evitalife Pharma Private Limited is U24233DL2012PTC229963.

Where is Evitalife Pharma Private Limited headquartered?

Evitalife Pharma Private Limited is headquartered at 1869/A-14 Basement Govindpuri Extension Kalkaji, New Delhi, Delhi, 110019.

When was Evitalife Pharma Private Limited incorporated?

Evitalife Pharma Private Limited was incorporated on 14 January 2012.

Who are the current directors of Evitalife Pharma Private Limited?

The current directors of Evitalife Pharma Private Limited are

What is the primary industry of Evitalife Pharma Private Limited?

The primary industry of Evitalife Pharma Private Limited is Manufacturing.

Is Evitalife Pharma Private Limited a listed company?

Evitalife Pharma Private Limited is unlisted.

What is the capital structure of Evitalife Pharma Private Limited?

The authorized capital of Evitalife Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹2.00 M.

What is the compliance status of Evitalife Pharma Private Limited?

The compliance status of Evitalife Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available